


TherimuneX Pharmaceuticals Email Formats
Biotechnology Research • Philadelphia, Pennsylvania, United States • 1-10 Employees
Key Contact at TherimuneX Pharmaceuticals
James Thacker
President & Chief Science Officer
Company overview
| Headquarters | Drexel University College of Medicine, 2900 Queen Lane, G44b, Philadelphia, Pennsylvania 19129, US |
| Phone number | +12155896418 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Therapeutic Peptides And Inflammasome Response |
| Employees | 1-10 |
| Socials |
About TherimuneX Pharmaceuticals
TherimuneX, with laboratories at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, is developing technology relating to a new family of endogenous lipopeptides and their immune regulating properties. The TherimuneX scientific discovery has led to the development of a new therapeutic peptide for treating and preventing infectious diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
TherimuneX Pharmaceuticals has never raised funding before.
TherimuneX Pharmaceuticals Tech Stack
Discover the technologies and tools that power TherimuneX Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Web servers
Frequently asked questions
4.8
40,000 users



